Dainippon Sumitomo Pharma Receives Approval for Antifungal Agent AmBisome.Tokyo, Japan, Apr 21, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Dainippon Sumitomo Pharma announced on April 20 that it has received approval for AmBisome for Injection 50mg, a liposomal formulation of the antifungal agent amphotericin B, from the Ministry of Health, Labor and Welfare. An agent discovered by US company Gilead Sciences, AmBisome is indicated for the treatment of infections caused by Aspergillus Aspergillus Any fungus of the genus Aspergillus of the Fungi Imperfecti (form-class Deuteromycetes). Species for which the sexual phase is known are placed in the order Eurotiales. A. niger causes black mold on some foods; A. niger, A. flavus, and A. , Candida and Cryptococcus Cryptococcus /Cryp·to·coc·cus/ (-kok´us) a genus of yeastlike fungi, including C. neofor´mans, the cause of cryptococcosis in humans.cryptococ´cal Cryp·to·coc·cus n. as well as febrile febrile /feb·rile/ (feb´ril) pertaining to or characterized by fever. feb·rile adj. Of, relating to, or characterized by fever; feverish. neutropenia with possible fungal infection. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion